118 related articles for article (PubMed ID: 22111314)
21. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
22. A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients.
Fahey TP; Peters TJ
Br J Gen Pract; 1996 Nov; 46(412):655-9. PubMed ID: 8978111
[TBL] [Abstract][Full Text] [Related]
23. Beyond hypertension toward guidelines for cardiovascular risk reduction.
Volpe M; Alderman MH; Furberg CD; Jackson R; Kostis JB; Laragh JH; Psaty BM; Ruilope LM
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1068-74. PubMed ID: 15533736
[TBL] [Abstract][Full Text] [Related]
24. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
25. [The Tanno and Sobetsu study].
Ohnishi H; Saitoh S; Shimamoto K
Nihon Rinsho; 2010 May; 68(5):839-42. PubMed ID: 20446579
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular risk factors in the Japanese northeastern rural population.
Ohsawa M; Itai K; Tanno K; Onoda T; Ogawa A; Nakamura M; Kuribayashi T; Yoshida Y; Kawamura K; Sasaki S; Sakata K; Okayama A
Int J Cardiol; 2009 Nov; 137(3):226-35. PubMed ID: 18707775
[TBL] [Abstract][Full Text] [Related]
27. [Tanno-Sobetsu chou study].
Shimamoto K; Miura T; Saito S
Nihon Rinsho; 2006 Aug; 64 Suppl 6():104-7. PubMed ID: 16981528
[No Abstract] [Full Text] [Related]
28. An observational study to evaluate the clinical practice of cardiovascular risk management among hypertensive patients in Turkey.
Kozan O;
Turk Kardiyol Dern Ars; 2011 Sep; 39(6):445-55. PubMed ID: 21918313
[TBL] [Abstract][Full Text] [Related]
29. [Dolichoarteriopathy (kinking, coiling,tortuosity) of the carotid arteries and cardiovascular risk factors].
Prencipe G; Pellegrino L; Vairo F; Tomaiuolo M; Furio OA
Minerva Cardioangiol; 1998; 46(1-2):1-7. PubMed ID: 9780615
[TBL] [Abstract][Full Text] [Related]
30. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
[TBL] [Abstract][Full Text] [Related]
31. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
Ravera M; Paoletti E
Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
[TBL] [Abstract][Full Text] [Related]
32. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
33. [Impact of mild hypertension on the risks of cardiovascular disease: the Hisayama Study].
Arima H; Kiyohara Y
Nihon Rinsho; 2008 Aug; 66(8):1453-7. PubMed ID: 18700541
[TBL] [Abstract][Full Text] [Related]
34. Blood pressure variability and cardiovascular risk in treated hypertensive patients.
Pierdomenico SD; Lapenna D; Di Tommaso R; Di Carlo S; Esposito AL; Di Mascio R; Ballone E; Cuccurullo F; Mezzetti A
Am J Hypertens; 2006 Oct; 19(10):991-7. PubMed ID: 17027816
[TBL] [Abstract][Full Text] [Related]
35. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study.
Kokubo Y; Okamura T; Watanabe M; Higashiyama A; Ono Y; Miyamoto Y; Furukawa Y; Kamide K; Kawanishi K; Okayama A; Yoshimasa Y
Hypertens Res; 2010 Dec; 33(12):1238-43. PubMed ID: 20927111
[TBL] [Abstract][Full Text] [Related]
36. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.
Gavish D; Leibovitz E; Elly I; Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Sep; 4(9):694-7. PubMed ID: 12440233
[TBL] [Abstract][Full Text] [Related]
37. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
38. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
Ruilope LM; Segura J
Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303
[TBL] [Abstract][Full Text] [Related]
39. Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study.
Arima H; Tanizaki Y; Kiyohara Y; Tsuchihashi T; Kato I; Kubo M; Tanaka K; Ohkubo K; Nakamura H; Abe I; Fujishima M; Iida M
Arch Intern Med; 2003 Feb; 163(3):361-6. PubMed ID: 12578518
[TBL] [Abstract][Full Text] [Related]
40. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
Shimada K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimamoto K; Tanaka H; Yoshiike N
Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
